Fujifilm Social Bond

FUJIFILM Holdings Corporation has identified “Health” as one of the priority areas in its corporate social responsibility (CSR) plan “Sustainable Value Plan 2030” ending March 2031. As part of the Company’s health goals, Fujifilm will improve access to healthcare and medicine around the world through our cutting-edge products and services across prevention, diagnosis and treatment.
Fujifilm plans to issue a social bond offering in April 2022. It will be used to finance the Company’s biopharmaceutical contract development and manufacturing business (Bio CDMO business), which contributes to fulfilling unmet medical needs and improving medical accessibility across the globe. 

Social Bond

Name Timig of issue Issue amount Redemption
maturity date
Interest rate
1 FUJIFILM Holdings Corporation
16th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
April 20, 2022 40 billion yen April 18, 2025 0.100%
2 FUJIFILM Holdings Corporation
17th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
April 20, 2022 40 billion yen April 20, 2027 0.195%
3 FUJIFILM Holdings Corporation
18th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
April 20, 2022 20 billion yen April 20, 2029 0.304%
4 FUJIFILM Holdings Corporation
19th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
April 20, 2022 20 billion yen April 20, 2032 0.374%

Summary of Social Bond

Name FUJIFILM Holdings Corporation 16th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
FUJIFILM Holdings Corporation 17th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
FUJIFILM Holdings Corporation 18th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
FUJIFILM Holdings Corporation 19th Series of Unsecured Corporate Bonds
(with inter-bond pari passu clause) (Social bonds)
Timing of issue April 20, 2022
Launch date April 14, 2022
Maturity 3 years 5 years 7 years 10 years
Issue amount 40 billion yen 40 billion yen 20 billion yen 20 billion yen
Interest rate 0.100% 0.195% 0.304% 0.374%
Use of proceeds Refinance existing investments related to capital investments for new manufacturing sites, M&A, manufacturing capacity expansion and development for high-efficiency and high-productivity technologies, etc., on Bio CDMO business
Lead managers Daiwa Securities Co. Ltd. (book runner)
Nomura Securities Co., Ltd.
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
Structuring agent* Daiwa Securities Co. Ltd.
Second party opinoin DNV Business Assurance Japan K.K.
Credit ratings AA(R&I)、A2(MDY)

*Entities that assist with the issuance of Social Bonds by undertaking tasks such as drawing up the framework for the bond issuance and obtaining a second party opinion.